Optimizing safety surveillance for COVID-19 vaccines.

Chandler RE

Nat Rev Immunol 20 (8) 451-452 [2020-08-00; online 2020-06-20]

Type: Review

PubMed 32555401

DOI 10.1038/s41577-020-0372-8

Crossref 10.1038/s41577-020-0372-8

pii: 10.1038/s41577-020-0372-8
pmc: PMC7298922


Publications 7.1.2